Skip to Main Content

Advertisement

Skip Nav Destination

Fibronectin Contributes to a BRAF Inhibitor–driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2

Mol Cancer Res (2023) 21 (9): 867–880.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Hannah M. Hicks
  • Veronica L. Nassar
  • Jane Lund
  • Madison M. Rose
  • Rebecca E. Schweppe
Cancer Biology & Therapy (2024) 25 (1)
  • Efstathios T Pavlidis
  • Ioannis N Galanis
  • Theodoros E Pavlidis
World Journal of Clinical Oncology (2023) 14 (12): 570.
Close Modal

or Create an Account

Close Modal
Close Modal